Drug & medication recalls Moderate risk

American Health Packaging recalls Raloxifene Hydrochloride Tablets, USP, 60 mg, 30 Tablets (3 x 10 blister cards), Rx Only, Packaged and Distributed by:…

Recall date
December 4, 2019
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
D-0854-2020
FDA classification
Class II
Brand / firm
American Health Packaging
Sold / distributed
Nationwide within the United States

Why it was recalled

Failed Dissolution Specifications: Low out of specification results obtained during stability testing.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Raloxifene Hydrochloride Tablets, USP, 60 mg, 30 Tablets (3 x 10 blister cards), Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC carton: 60687-266-21; NDC Unit Dose: 60687-266-11

Get recall alerts

Free email alert whenever American Health Packaging has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: American Health Packaging